Categories
Cardiovascular
Diagnostics
Endocrinology
Health Insurance
Medical Devices
Mental Health
Nutrition
Oncology
Public Health
Sexual Health
very Fat dildos!
Popular Articles

A Compound Found In The Sea Provides Promising New Treatment For Neuropathic Pain
A paper just published in the British Journal of Pharmacology reports that a compound originally isolated from a soft coral (Capnella imbricate) could lead scientists to develop a new variety of treatments for neuropathic pain. This composite is collected at Green Island off Taiwan and could be a new option for treatment. Neuropathic pain is chronic and occasionally follows damage to the nervous system. Presently this type of pain is very poorly controlled by the usual analgesics: aspirin like drugs (NSAIDS) or even opioids like morphine. New treatments are urgently required.
diet pills Prezzi dentisti croazia
New Method For Breast Cancer Biomarker Discovery Developed By VBI Researchers
Three researchers from the Virginia Bioinformatics Institute (VBI) at Virginia Tech have developed and evaluated a new one-step bioanalytical approach that allows them to profile in detail complex cellular extracts of proteins. The method has allowed the scientists to look at how the levels of proteins change in breast cancer cells when they are treated with hormones or cancer drugs like tamoxifen.
News of the day
Some Groups Say Iowa HIV Transmission Law Worsens Stigma, Hinders Testing Efforts
Some Iowa groups are concerned that the state"s criminal HIV transmission law adds to the stigma associated with the virus and hampers testing efforts, and are urging lawmakers to revisit the law, the Iowa Independent reports. According to the Independent, criminal transmission of HIV is classified among the second-most serious felonies that can be committed in the state. Those that have been convicted under the law have been sentenced to a few months to several decades in prison. Former state Rep. Ed Fallon (D) who supported the 1998 law, said, "It seems to me that since it is now 11, almost 12, years later, it wouldn"t be [a] bad time to take a look at it again," adding that "surely [there] are some tweaks or changes that the legislature could consider relevant to this law, especially with all the new knowledge we have of the disease" (Waddington, 7/1).
Diagnostics

Genomic Medicine Institute Adds Seven Additional Illumina Genome Analyzers To Expand Capacity For Asian 100 Genome Project

Illumina (NASDAQ:ILMN) announced that the Genomic Medicine Institute (GMI) at Seoul National University College of Medicine in Korea, purchased seven additional Illumina Genome AnalyzerIIx sequencing systems, expanding the capacity of their recently established Asian Genome Center to 10 Illumina sequencing systems. "GMI"s decision to add seven additional Genome Analyzers is further validation that our sequencing platform is delivering leading performance with its unmatched rate of daily output, ease of use and proven paired-end sequencing capabilities," said Tim Orpin, general manager of Illumina"s Asia Pacific Region. Dr. Jeong-Sun Seo, director of the Genomic Medicine Institute, and his team, have completed a deep sequencing project of the Korean genome and the work was published online in Nature July 8, 2009. "This publication demonstrates the global competitiveness of GMI"s technological capabilities and provides a practical example of Korean bio-medical excellence," said Dr. Seo. GMI is the second largest Genome Center in Asia and the largest center that focuses exclusively on human genome analysis and its clinical application in Asia. As part of the Asian 100 Genome Project, GMI plans to complete the whole genome analysis of 100 Asian individuals by 2012 and establish an Asian Genome Database with comprehensive genome information specifically targeting Asian populations. About the Illumina Genome Analyzer Designed for facilities of all sizes, the Illumina Genome Analyzer has been adopted across genome centers worldwide, plus individual research labs, core and service facilities, and biotechnology and pharmaceutical companies. Generating over 20 Gigabases of sequence data, the Genome Analyzer offers the highest rate of daily output and the simplest and most user-friendly workflow. The Genome Analyzer also offers the broadest set of supported applications, including those used to profile and discover novel transcripts, to create a high-resolution genome-wide map of DNA-protein binding sites and to sequence entire human genomes to greater than 30x coverage. For more information about the Genome Analyzer and to read what customers are doing with Illumina"s sequencing technology, please visit http://www.illumina.com/sequencing. Illumina


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):

© Copyright 2009